(Q45522159)

English

Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

11

object named as

Ann M Arvin

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Leigh Zerboni

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Stewart Hinchliffe

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Marvin H Sommer

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hideki Ito

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jaya Besser

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Shaye Stamatis

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jason Cheng

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Daniel Distefano

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Nikolai Kraiouchkine

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Alan Shaw

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

332

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

337-346

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Varicella vaccine: genesis, efficacy, and attenuation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Varicella and zoster in children after kidney transplantation: long-term results of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

The complete DNA sequence of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Live-attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

A long-term prospective study of varicella vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Lymphocyte-associated viremia in varicella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Zoster in normal children after varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Varicella vaccination in children after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Live vaccine used to prevent the spread of varicella in children in hospital

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

Clinical trials of varicella vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.10.047

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2004.10.047

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45522159&oldid=2077388091"